Ocular manifestations of retinoids;Manifestations oculaires des retinoides

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 6-7, 1998, Pages 438-442

  Michel, J L ^a,b   Valanconny, C ^a   Gain, Ph ^a   Montelimard, N ^a   Tchaplyguine, F ^a   Cambazard, F ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHIBOXINE; ISOTRETINOIN; NEOMYCIN; NORFLOXACIN; PICLOXYDINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; CONJUNCTIVA EPITHELIUM; CONJUNCTIVITIS; CONTACT LENS; CORNEA EROSION; EYE IRRITATION; EYE TOXICITY; HUMAN; LACRIMATION; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PERSONAL HYGIENE; SKIN DISEASE; STAPHYLOCOCCUS; TERATOGENICITY; VISUAL DISORDER; CHEMICALLY INDUCED DISORDER; EYE DISEASE; REVIEW;

CONJUNCTIVITIS; EYE DISEASES; HUMANS; ISOTRETINOIN;

EID: 0032113965     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Egger SF, Huber-Spitzy V, Bohler K, Raff M, Scholda C, Barisani T, Vecsei VIP. Ocular side effects associated with 13 cis-retinoic acid therapy for acnes vulgaris: clinical features, alterations of tearfilm and conjonctival flora. Acta Ophthalmol Scand 1995;73:355-7.
2. Gold JA. Shupack JL, Nemec MA. Ocular side effect of the retinoids. Int J Dermatol 1989;28:218-25.
3. Egger SF, Huber-Spitz YV, Bohler K, Scholda C. Alterations of the conjunctival flora and ocular complications during isotretinoin therapy of acnes vulgaris. Inv Ophthalmol Vis Sci 1994;35:1293.
4. Blackman HJ, Peck GL, Olsen TG, BergsmADR. Blepharoconjunctivitis: a side effect of 13-cis retinoic acide therapy for dermatologic disease. Ophthalmology 1979;86:753-8.
5. Fraunfelder FT, Labbaico JM, Meyer MS. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol 1985;100:534-7.
6. Lerman S. Ocular side effects of Accutane therapy. Lens and Eye Tox. Research 1992;9:429-38.
7. Fraunfelder FT. Ocular side effects of isotretinoin therapy. JAMA 1983;250:2545.
8. Stables GI, Mac Kie RM. The eye and retinoids drugs. Retinoids Today and Tomorrow 1993;31:4-6.
9. Layton AM, Cunliffe WJ. Ocular problems in contact lens wearers and non contact lens wearers on isotretinoin practical guidelines. J Dermatol Treat 1990;1:247-49.
10. Lebowitz MA, Berjon DS. Ocular effects of oral retinoids. J Am Acad Dermatol 1988;19:209-11.
11. Milson J, Jones DH, King K, Cunliffe WJ. Ophthalmological effects of 13-cis retinoic acid therapy for acnes vulgaris. Br J Dermatol 1982;107:491.
12. Ensink BW, Van Voorst Vader PC. Ophthalmological side-effects of 13-cis retinoid therapy. Br J Dermatol 1983;108:627.
13. Scorolli L, Godano A, Bettoli V, Pizzino D, Varotti C. Kératoconjonctivite sèche en cours de traitement avec de l'acide 13-cis rétinoïque (isotrétinoïne). Ophtalmologie 1988;2:117-9.
14. King K, Jones DH, Daltrey DC. A double blind study of the effects of 13-cis-retinoic acid on acne sebum excretion rate and microbial population. Br J Dermatol 1982;107:583
15. Strauss JS, Stranieri AM. Farrell LN. The effect of marked inhibition of sebum production with 13-cis-retinoic acìd on skin surface lipid composition. J Invest Dermatol 1980;74:66.
16. Smolin G, Okumoto M. Staphylococcus blepharitis. Arch Ophthalmol 1977;95:812-6.
17. Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J Am Optom Assoc 1988;59:221-4.
18. Graham ML, Corey R, Califf R. Isotretinoin and staphylococcus aureus infection: a possible association. Arch Dermatol 1986;122:815-7.
19. Hazen PG, Carney JM, Langsten RH, Meisler DM. Corneal effect of isotretinoin: possible exacerbation of corneal neovascularization in a patient with the keratitis, ichtyosis, deafness (« KID ») syndrome. J Am Acad Dermatol 1986;14:141-2.
20. Mc Cormack LS, Turner ML. Photosensitivity and isotretinoin therapy. J Am Acad Dermatol 1983;9:273-8.
21. Weiss J, Degnan M, Leupold R, Lumpkin LR. Bilateral corneal opacities. Occurence in a patient treated with oral isotretinoin. Arch Dermatol 1981;117:182-3.
22. Herman DC, Dyer JA. Anterior subcapsular cataract as a possible adverse ocular reaction to isotretinoin. Am J Ophthalmol 1987;103:236-7.
23. Heuberger A, Buchi ER. Irreversible Katarakt als mögliche Neben-wirkung von Isotretinoin. Klin Monatsbl Augenheilkd 1994;204:465-7.
24. Palestine AG. Transient acute myopia resulting from isotretinoin (Accutane) therapy. Ann Ophthalmol 1984;16:660-2.
25. Roytraan M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988;42:399-400.
26. Welcher RG, Denman ST, Cunningham WJ, Hanifin JM. Abnormal night vision, dark adaptation, and electrophysiologic responses associated with isotretinoin therapy for acne. Clin Res 1985;33:158A.
27. Denman ST, Welcher RG, Hanifin JM, Cunningham WJ, Phipps R. Abnormal night vision and altered dark adaptometry in patients treated with isotretinoin for acne. J Am Acad Dermatol 1986;14:692-3.
28. Welcher RG, Denman ST, Hanifin JM, Cunningham W. J. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol 1986;831-7.
29. Watson NJ, Hutchinson CH. Rod and cone malfunction as a manifestation of isotretinoin therapy. A case report. J Dermatol Treat 1992;3:205-7.
30. Maclean H, Wright M, Choi D, Tidman MJ. Abnormal night vision with isotretinoin therapy for acne. Clin Exp Dermatol 1995;20:86.
31. Brown RD, Grattan CEH. Visual toxicity of synthetic retinoids. Br J Ophtalmol 1989;73:286-8.
32. Grattan CEH., Brown RD, Cowan MA, Ryatt KS. Retinoids and the eye reduced rod function with isotretinoin. Br J Dermatol 1987;117(S32):23.
33. Investigational drug brochure: RO 04-3780. 13 cis retinoic acid. Hoffman-La Roche Inc, Nutley NJ, February 1978.
34. Campbell JP, Grekins RC, Ellis CN, Retinoid therapy is associated with excess granulation tissue responses. J Am Acad Dermatol 1983;9:708-13.
35. Blumenthal G. Paronychia and pyogenic granuloma-like lesions with isotretinoin. J Am Acad Dermatol 1984;10:677-8.
36. Bigby M, Stern RS. Adverse reactions to isotretinoin. A report from the adverse drug reaction reporting system. J Am Acad Dermatol 1988;18:543-52.
37. Maddalena MA. Transient myopia associated with glaucoma and retinal edema. Arch Ophtalmol 1968;80:186-8.
38. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin a preparation. Neurology 1984;34:1509-11.
39. Morriee G, Haverner WH, Kapetansky F. Vitamin A intoxication as cause of pseudotumor cecebri. JAMA 1960; 72:1802-5.
40. FDA Drug Bull. Adverse effects with isotretinoin. J Am Acad Dermatol 1984;10:519-21.
41. Koch-Weser J. Benign intracranial hypertension in an adult after tetracycline therapy. JAMA 1967;200:169-71.
42. Giles C. Intracranial hypertension and tetracycline therapy. Am J Ophtalmol 1971;72:981-2.
43. Beran RG. Pseudotumor cerebri associated with minocycline therapy for acnes. Med J Aust 1980;1:323-4.
44. Walters BNJ, Gubbay SS. Tetracycline and benign intracranial hypertension: report of five cases. Brit Med J 1981;282:19-20.
45. Benke PJ. The isotretinoin teratogen syndrome. JAMA 1984;251:3267-9.
46. Stern RS, Rosa F, Baum C. Isotretinoin and pregnancy. J Am Acad Dermatol 1984;10:851-9.
47. Ferrat S, De Juan E, Campochiaro PA. The effect of oral 13-cis-retinoic acid and retinal attachment after surgical repair in eyes with proliferative vitreoretinopathy (P.V.R.). Inv. Ophtalmol. Vis Sci 1994;35:1532.